Vitamin and mineral supplementation should be individualized based on dietary intake assessment and laboratory findings rather than routinely prescribed
For patients with cardiovascular disease but not chronic kidney disease, GLP-1 receptor agonists reduce overall mortality, with an NNT of 59 (95% CI, 40 to 112) over five years
Protein Improves Consistency Patients who prioritize protein often find it easier to stick with their GLP-1 diet guidelines , even when appetite is low
Safety Considerations and Who Should Have This Conversation with Their Provider GLP-1 medications are not suitable for everyone, and individual tolerability conversations should include assessment of personal medical history, current medications, and baseline gastrointestinal health
Patients should view nutritional optimization as an integral component of semaglutide therapy rather than an optional consideration, recognizing that medication efficacy and long-term health outcomes depend substantially on maintaining adequate protein and overall nutrient intake during weight loss
Dont overdo it